What is NDC 55150-228?

55150-228 is the product NDC for Tigecycline, Tigecycline 50 mg/1 injection, powder, lyophilized, for solution, listed with the FDA by Eugia US LLC. It has 1 package NDC, shown above in 10- and 11-digit form.

Eugia US LLC, NDC labeler code 55150. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Tigecycline?

4 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Tigecycline NDC 55150-228 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)55150-228Labeler and product segments. Claims need a package NDC.

Product NDC at billing width55150-0228Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
55150-228-10	5515002281055150022810	10 VIAL, SINGLE-DOSE in 1 CARTON (55150-228-10) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-DOSEMarketed from Jun 11, 2019

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Tigecycline
Generic name (nonproprietary): tigecycline
Active ingredients: Tigecycline — 50 mg/1
Dosage form: Injection, Powder, Lyophilized, For solution
Route: Intravenous
Labeler: Eugia US LLCNDC labeler code 55150
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 206335
Marketing start: Jun 11, 2019
Listing expires: Dec 31, 2026
Other FDA classes: Tetracyclines (Chemical structure)
Identifiers: Product ID 55150-228_a5262444-a326-478c-a6d6-b515ef3d1219SPL ID a5262444-a326-478c-a6d6-b515ef3d1219SPL set ID dd58e0c3-d8a8-4cf2-96f8-9dd08f309579RxCUI 581531UNII 70JE2N95KRUPC 0355150228102
Pharmacologic class: Tetracycline-class Antibacterial

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N455150022810 followed by a unit qualifier and the quantity

Package 55150-0228-10. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Apr 18, 2025. This label includes a boxed warning.

Indications (excerpt from the label)

Tigecycline for injection is a tetracycline class antibacterial indicated in patients 18 years of age and older for: Complicated skin and skin structure infections (1.1) Complicated intra-abdominal infections (1.2) Community-acquired bacterial pneumonia (1.3) Limitations of Use : Tigecycline for injection is not indicated for treatment of diabetic foot infection or hospital-acquired pneumonia, including ventilator-associated pneumonia (1.4) . To reduce the development of drug-resistant bacteria and maintain the effectiveness of tigecycline and other antibacterial drugs, tigecycline should be used only to treat infections that are proven or strongly suspected to be caused by bacteria (1.5). 1…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 55150-228

What is NDC 55150-228?: 55150-228 is the product NDC for Tigecycline, Tigecycline 50 mg/1 injection, powder, lyophilized, for solution, listed with the FDA by Eugia US LLC. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Tigecycline.
What is the active ingredient?: Tigecycline.
Who is the labeler?: Eugia US LLC, NDC labeler code 55150. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Tigecycline?: 4 other product NDCs are listed under this name. See all Tigecycline NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Tigecycline NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Tigecycline	Tigecycline 50 mg/5mL	Injection, Powder, Lyophilized, For solutionIntravenous	Meitheal Pharmaceuticals Inc.	71288-019	71288-0019-11
Tigecycline	Tigecycline 50 mg/5mL	Injection, Powder, Lyophilized, For solutionIntravenous	Apotex Corp	60505-6098	60505-6098-01
Tigecycline	Tigecycline 50 mg/5mL	Injection, Powder, Lyophilized, For solutionIntravenous	Amneal Pharmaceuticals LLC	70121-1647	70121-1647-07
Tigecycline	Tigecycline 50 mg/10mL	Injection, Powder, Lyophilized, For solutionIntravenous, Parenteral	Sandoz Inc	0781-3481	00781-3481-92